CRL vs MLKN · rev $2.00B vs P/E 15, rev $3.84B
Charles River Laboratories (CRL) versus MillerKnoll Inc (MLKN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MillerKnoll Inc (MLKN) is a furnishings, fixtures & appliances company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MLKN revenue for 2026-05-30 was $3.84B. Net income was $91.5M. Revenue was up 4.7% from 2025-05-31 to 2026-05-30. MLKN currently screens at market cap $1.39B and trailing P/E 15.5.
CRL currently screens at market cap $7.78B. MLKN currently screens at market cap $1.39B and trailing P/E 15.5.
Not investment advice. Open the CRL and MLKN stock pages for the full models.
Not investment advice.